Jascayd 9 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F65F8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,915
Award facts
- Contract value 100% obligated
- $10,914.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 9, 2026, the Defense Logistics Agency awarded a delivery order valued at $10,914.63 to AmerisourceBergen Drug Corp for the supply of Jascayd 9 mg tablets (60-count units). The contract is firm fixed-price and non-set-aside, with an ultimate completion date of February 2, 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999.00 comprehensive pharmaceutical supply agreement valued through December 31, 2031 that serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its extensive portfolio with the Defense Logistics Agency and its Medical Supply Chain. The company has demonstrated capability to meet federal procurement requirements through open competition, with contract awards consistently structured as delivery orders with firm fixed pricing. The underlying IDC with DLA encompasses specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F65F8?
SPE2DR26F65F8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F65F8 worth?
The government has obligated $10,915 on SPE2DR26F65F8.
Is contract SPE2DR26F65F8 an order under another contract?
Yes. SPE2DR26F65F8 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F65F8 competed?
The extent of competition for SPE2DR26F65F8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award